Comments

Transcript

About this Series

Leading hematologists/oncologists from the City of Hope Cancer Center in Duarte, California, explore the new options for patients with relapsed multiple myeloma. A growing array of targeted therapies, immunotherapies (including highly anticipated CAR T-cell therapy), improved ways of detecting disease and identifying appropriate therapies, and evolving strategies of stem cell transplant are contributing to increased survival and improved quality of life for patients with this devastating disease.

Show More

Who's Who
{{#each bp-whos-who.people}}
doc
●●●
{{{title}}}
{{{name}}} {{{addComma prof}}}
{{{desc}}}
{{#if disclosureTitle }} Disclosure
Disclosure
{{{disclosureTitle}}}
{{{disclosureText}}}
{{/if}}
More on Multiple Myeloma